Healthcare – Page 7

The M&A Opportunity in Behavioral Health

The M&A Opportunity in Behavioral Health

Eric Yetter2024-01-22T11:00:47+00:00Blogs, Healthcare|

The behavioral health market is highly fragmented which is always a catalyst for consolidation. COVID-19 added to that and created an increased opportunity in M&A activity.

ENT & Allergy Report – Q2 2021 Acquisition Activity and Outlook

ENT & Allergy Report – Q2 2021 Acquisition Activity and Outlook

dev2024-02-12T22:57:15+00:00ENT & Allergy, Healthcare|

Quiet Quarter for ENT & Allergy Practices Acquisitions. Expect Increasing Opportunity for Large Practice Sellers

Although we did not track any reported transactions in Q2, the first half of 2021 delivered three reported ENT practice acquisitions.

Dermatology Report – Q2 2021 Acquisition Activity and Outlook

Dermatology Report – Q2 2021 Acquisition Activity and Outlook

dev2024-02-12T22:57:14+00:00Dermatology, Healthcare|

Core Dermatology Buyers Remain Active in 2021. Window of Opportunity May Be Starting to Close for Smaller Practices

The second quarter of 2021 delivered six reported dermatology practice acquisitions.

Behavioral Health Report – Q2 2021 Acquisition Activity and Outlook

Behavioral Health Report – Q2 2021 Acquisition Activity and Outlook

dev2024-02-12T22:57:12+00:00Behavioral Health, Healthcare|

Transaction Volume Remains High Throughout Behavioral Health

The second quarter of 2021 delivered thirty-four reported behavioral health transactions, continuing a strong consolidation surge within the industry. We generally expect high deal flow throughout 2021, supported by increasing private equity interest, a favorable government, and a seller pool that is ready to transact.

Women’s Health Report – Q2 2021 Acquisition Activity and Outlook

dev2024-01-22T11:00:55+00:00Women's Health|

Women’s Health Deals Dip in Q2. Expect Resurgence by End of Year

Partners Group recaps Axia. The second quarter of 2021 delivered one reported Women's Health practice acquisition.

Urology Report – Q2 2021 Acquisition Activity and Outlook

Urology Report – Q2 2021 Acquisition Activity and Outlook

dev2024-01-22T11:00:55+00:00Urology|

Quiet Quarter for Urology Practice Acquisitions. Increase Expected for Second Half of 2021

The second quarter of 2021 delivered one reported urology practice acquisitions, coming down form the flurry of activity in Q1.

Orthopedics Report – Q2 2021 Acquisition Activity and Outlook

Orthopedics Report – Q2 2021 Acquisition Activity and Outlook

dev2024-01-22T11:00:51+00:00Orthopedics|

Orthopedic Platforms Continue to Form - Positioning for Market Share and Private Equity Recapitalization

The second quarter of 2021 delivered three reported orthopedic practice acquisitions, including the formation of Ortho Alliance New Jersey which included seven orthopedic practices in New Jersey joining to form the largest orthopedic group in the state.

Ophthalmology Report – Q2 2021 Acquisition Activity and Outlook

Ophthalmology Report – Q2 2021 Acquisition Activity and Outlook

dev2024-01-22T11:00:51+00:00Ophthalmology|

After a Strong First Half, 2021 Is Now Looking Like a True Window of Opportunity for Ophthalmology Deals

The second quarter of 2021 delivered twenty-two reported ophthalmology practice acquisitions, continuing the surge of M&A activity within the specialty.

Home Health & Hospice Report – Q2 2021 Acquisition Activity and Outlook

Home Health & Hospice Report – Q2 2021 Acquisition Activity and Outlook

dev2024-01-22T11:00:51+00:00Home Health & Hospice|

Transaction Volume Continues to Increase Across Home Health & Hospice

The second quarter of 2021 delivered 40 reported home health and hospice transactions continuing a steady upward trend of M&A activity within the industry.

Gastroenterology Report – Q2 2021 Acquisition Activity and Outlook

Gastroenterology Report – Q2 2021 Acquisition Activity and Outlook

dev2024-01-22T11:00:51+00:00Gastroenterology|

Gastroenterology Acquisition Activity Remains High in Q2 2021 – Major Opportunity for Selling Physicians

The second quarter of 2021 delivered eight gastroenterology practice acquisitions, coming down from the flurry of activity in Q1. Still, gastroenterology remains one of the most active and attractive PPM investment opportunities.